| 注册
首页|期刊导航|中国药房|全球短缺药品监测制度的循证评价

全球短缺药品监测制度的循证评价

张伶俐 陈哲 曾力楠 归舸 张扬 李佳莲 黄宗瑶 宋好鑫

中国药房2017,Vol.28Issue(34):4753-4758,6.
中国药房2017,Vol.28Issue(34):4753-4758,6.DOI:10.6039/j.issn.1001-0408.2017.34.01

全球短缺药品监测制度的循证评价

Evidence-based Evaluation of Monitoring System for Global Short Drugs

张伶俐 1陈哲 2曾力楠 3归舸 1张扬 2李佳莲 3黄宗瑶 1宋好鑫2

作者信息

  • 1. 四川大学华西第二医院药学部,成都 610041
  • 2. 四川大学华西第二医院循证药学中心,成都 610041
  • 3. 出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041
  • 折叠

摘要

Abstract

OBJECTIVE:To systematically evaluate the monitoring system for global short drugs,and provide evidence-based reference and policy recommendations for developing the short drug monitoring in China. METHODS:Relevant literatures pub-lished in PubMed,Embase,CNKI,Wanfang,VIP database from building to Apr. 3rd in 2017 were retrieved by using"Drugs (cheap drugs,essential medicines,emergency drugs) storage""Short drugs""Insufficient supply of drugs""Drug shortage"as Chinese keywords,and"Drug storage""Out-of-stock drug""Stortage of medicine""Stock out of medicine"as English keywords. Literatures about monitoring system for short drugs in Baidu,Google and national or regional health administration websites were collected,and general information,data collection,data validation,data reporting method,feedback and improvement measures of monitoring system were extracted. RESULTS & CONCLUSIONS:Totally 25 literatures were included,20 national or regional health administration websites were retrieved. 11 countries and European Union had established monitoring system for short drugs. The main reporting agencies in each country were different,which were production enterprises,business enterprises and medical in-stitutions. It was mainly reported by network. Data validation was mainly conducted by specialized departments or groups for short drugs in each country. The monitoring reporting included information of short drugs and discontinued drugs. Countermeasures in each country mainly included looking for alternative drugs,encouraging production,temporary import,looking for new or other sources of raw materials and speeding up the approval of short drugs. Besides, precautions included implementation relevant laws and guidelines for short drugs,and increasing the cooper-ation with non-government departments,etc. Monitoring sys-tem for short drugs needs to be further improved in China. Itis suggested to establish monitoring and early warning platform for short drugs,and hierarchical intervention mechanism,improv-ing relevant laws and developing guidelines on managing short drugs.

关键词

短缺药品/监测/制度/循证评价

Key words

Short drugs/Monitoring/System/Evidence-based evaluation

分类

医药卫生

引用本文复制引用

张伶俐,陈哲,曾力楠,归舸,张扬,李佳莲,黄宗瑶,宋好鑫..全球短缺药品监测制度的循证评价[J].中国药房,2017,28(34):4753-4758,6.

基金项目

国家卫生和计划生育委员会2017年委托课题(No.2017bwqt-008-wjw) (No.2017bwqt-008-wjw)

中国药房

OA北大核心CSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文